Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

asx

  • Home
  •  
  • asx



  • Most Read
  • Latest Comments
  • OncoSil Medical strengthens board with appointment of governance expert
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • OncoSil Medical strengthens board with appointment of governance expert
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • OncoSil Medical strengthens board with appointment of governance expert
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • OncoSil Medical strengthens board with appointment of governance expert
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • OncoSil Medical strengthens board with appointment of governance expert
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • OncoSil Gains Momentum in Germany as 120 Hospitals Secure Negotiation Rights
    OncoSil Gains Momentum in Germany as 120 Hospitals Secure Negotiation Rights
    • News

  • OncoSil Medical strengthens board with appointment of governance expert
    OncoSil Medical strengthens board with appointment of governance expert
    • News

  • Trading the ASX – Get your head around economic data releases
    Trading the ASX – Get your head around economic data releases
    • News

  • Cost cutting is all the rage right now
    Cost cutting is all the rage right now
    • News

  • Innodata pulls bid after Appen is forced to breach confidential details to ASX
    Innodata pulls bid after Appen is forced to breach confidential details to ASX
    • News

  • OncoSil Medical strengthens board with appointment of governance expert
    • News

    OncoSil Medical strengthens board with appointment of governance expert

    In a strategic move to bolster its governance and corporate strategy, OncoSil Medical Limited (ASX:OSL), a leader in pancreatic cancer treatment innovation, has today appointed Ms. Lel Smits as a Non-Executive Director. The addition of Ms. Smits, a renowned figure in corporate governance and investor relations, signals OncoSil’s commitment to enhancing its market position and

    Read More
    Public
  • Trading the ASX – Get your head around economic data releases
    • News

    Trading the ASX – Get your head around economic data releases

    Economic data releases play a crucial role in shaping trading activity on the Australian Securities Exchange (ASX), providing vital insights into the health and direction of the economy. As traders navigate the complexities of the ASX, understanding how key economic indicators influence individual stock prices and the market as a whole is vital. When significant

    Read More
    Public
  • Cost cutting is all the rage right now
    • News

    Cost cutting is all the rage right now

    In recent times, ASX-listed companies are increasingly adopting cost-cutting measures to navigate the challenging economic landscape – whilst its effect on companies bottom lines is possibly a reason to be quite bullish heading into reporting season. This trend has been driven by a combination of issues, namely; global economic uncertainties, inflationary pressures, and the need

    Read More
    Public
  • Innodata pulls bid after Appen is forced to breach confidential details to ASX
    • News

    Innodata pulls bid after Appen is forced to breach confidential details to ASX

    After having its contract with Google terminated, artificial intelligence company Appen (ASX: APX) has been kicked while down after getting trapped between rock and hard place, with leading data company Innodata to withdraw its takeover bid, citing a confidentiality breach. On March 12, 2024, Appen received a letter from the ASX inquiring about its price

    Read More
    Public
  • ASIC and RBA give green light to new ASX CHESS replacement after years of delays and failures
    • News

    ASIC and RBA give green light to new ASX CHESS replacement after years of delays and failures

    Questions regarding reliability, transparency and scalability came to the fore after the multi-asset exchange company Australian Stock Exchange (ASX: ASX) decided to replace its 25-year-old clearing and settlements system CHESS with blockchain tech in 2016. To do so, the ASX brought on the New York-based tech startup Digital Asset.  However, after multiple delays and issues,

    Read More
    Public
  • Digital Human platform building momentum as UNITH signs its most clients in September quarter
    • News

    Digital Human platform building momentum as UNITH signs its most clients in September quarter

    As more businesses around the world seek solutions to address unreliable staff and reduce excess payroll expenses, artificial intelligence company UNITH (ASX: UNT) is solving all of these problems for them, signing its most clients in a single quarter to its Digital Human platform.  Driving increased commercial activity has been tech advancements made in the

    Read More
    Public
  • 1
  • 2
  • 3
  • 4

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.